{
  "ticker": "AYA",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968022",
  "id": "02968022",
  "pages": 3,
  "price_sensitive": true,
  "date": "20250710",
  "time": "0855",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250710/pdf/06lnnz8s2t7q3r.pdf",
  "summary": "**Material Information Summary:**  \n\n- **First U.S. commercial contract signed**:  \n  - Five-year SaaS agreement with **Tanner Health**, valued at **US$0.6M (~AUD 0.9M)**.  \n  - First revenue expected in current quarter.  \n\n- **Commercial expansion pathway**:  \n  - Potential additional revenue from **Salix\u00ae Coronary Plaque** and **Coronary Flow** modules post-FDA clearance (eligible for U.S. reimbursement).  \n  - Platform integrated across **5 hospitals, cardiovascular centers, and 30 physician practices**.  \n\n- **Strategic milestone**:  \n  - Marks transition to **revenue-generating phase** in the U.S. market.  \n  - Active discussions with other U.S. hospital networks (e.g., Northeast Georgia Health System, Cone Health).  \n\n**Omitted**: Operational details, executive quotes, non-material partnership specifics.",
  "usage": {
    "prompt_tokens": 2297,
    "completion_tokens": 187,
    "total_tokens": 2484,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-09T23:21:23.934966"
}